SPY310.52+2.16 0.70%
DIA257.31-0.56 -0.22%
IXIC10,154.63+95.86 0.95%

SunTrust Robinson Humphrey Initiates Coverage On PTC Therapeutics with Buy Rating, Announces $78 Price Target

SunTrust Robinson Humphrey initiates coverage on PTC Therapeutics (NASDAQ:PTCT) with a Buy rating and a $78 price target.

Benzinga · -

SunTrust Robinson Humphrey initiates coverage on PTC Therapeutics (NASDAQ:PTCT) with a Buy rating and a $78 price target.